Cross-talk between immune system and microbiota in COVID-19
INTRODUCTION: Human gut microbiota plays a crucial role in providing protective responses against pathogens, particularly by regulating immune system homeostasis. There is a reciprocal interaction between the gut and lung microbiota, called the gut-lung axis (GLA). Any alteration in the gut microbiota or their metabolites can cause immune dysregulation, which can impair the antiviral activity of the immune system against respiratory viruses such as severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2.
AREAS COVERED: This narrative review mainly outlines emerging data on the mechanisms underlying the interactions between the immune system and intestinal microbial dysbiosis, which is caused by an imbalance in the levels of essential metabolites. The authors will also discuss the role of probiotics in restoring the balance of the gut microbiota and modulation of cytokine storm.
EXPERT OPINION: Microbiota-derived signals regulate the immune system and protect different tissues during severe viral respiratory infections. The GLA's equilibration could help manage the mortality and morbidity rates associated with SARS-CoV-2 infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Expert review of gastroenterology & hepatology - 15(2021), 11 vom: 15. Nov., Seite 1281-1294 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Baradaran Ghavami, Shaghayegh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Coronavirus |
---|
Anmerkungen: |
Date Completed 24.11.2021 Date Revised 02.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/17474124.2021.1991311 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM331948117 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM331948117 | ||
003 | DE-627 | ||
005 | 20231225214609.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/17474124.2021.1991311 |2 doi | |
028 | 5 | 2 | |a pubmed24n1106.xml |
035 | |a (DE-627)NLM331948117 | ||
035 | |a (NLM)34654347 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Baradaran Ghavami, Shaghayegh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cross-talk between immune system and microbiota in COVID-19 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.11.2021 | ||
500 | |a Date Revised 02.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Human gut microbiota plays a crucial role in providing protective responses against pathogens, particularly by regulating immune system homeostasis. There is a reciprocal interaction between the gut and lung microbiota, called the gut-lung axis (GLA). Any alteration in the gut microbiota or their metabolites can cause immune dysregulation, which can impair the antiviral activity of the immune system against respiratory viruses such as severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 | ||
520 | |a AREAS COVERED: This narrative review mainly outlines emerging data on the mechanisms underlying the interactions between the immune system and intestinal microbial dysbiosis, which is caused by an imbalance in the levels of essential metabolites. The authors will also discuss the role of probiotics in restoring the balance of the gut microbiota and modulation of cytokine storm | ||
520 | |a EXPERT OPINION: Microbiota-derived signals regulate the immune system and protect different tissues during severe viral respiratory infections. The GLA's equilibration could help manage the mortality and morbidity rates associated with SARS-CoV-2 infection | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Video-Audio Media | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Gut microbiota | |
650 | 4 | |a coronavirus | |
650 | 4 | |a gut microbial-host-immune axis | |
650 | 4 | |a gut-lung axis | |
650 | 4 | |a respiratory complications | |
700 | 1 | |a Pourhamzeh, Mahsa |e verfasserin |4 aut | |
700 | 1 | |a Farmani, Maryam |e verfasserin |4 aut | |
700 | 1 | |a Raftar, Shahrbanoo Keshavarz Azizi |e verfasserin |4 aut | |
700 | 1 | |a Shahrokh, Shabnam |e verfasserin |4 aut | |
700 | 1 | |a Shpichka, Anastasia |e verfasserin |4 aut | |
700 | 1 | |a Asadzadeh Aghdaei, Hamid |e verfasserin |4 aut | |
700 | 1 | |a Hakemi-Vala, Mojdeh |e verfasserin |4 aut | |
700 | 1 | |a Hossein-Khannazer, Nikoo |e verfasserin |4 aut | |
700 | 1 | |a Timashev, Peter |e verfasserin |4 aut | |
700 | 1 | |a Vosough, Massoud |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert review of gastroenterology & hepatology |d 2007 |g 15(2021), 11 vom: 15. Nov., Seite 1281-1294 |w (DE-627)NLM185080200 |x 1747-4132 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2021 |g number:11 |g day:15 |g month:11 |g pages:1281-1294 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/17474124.2021.1991311 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2021 |e 11 |b 15 |c 11 |h 1281-1294 |